TITLE

Comparison of Rapid Rhino and Merocel Nasal Packs in Endonasal Septal Surgery

AUTHOR(S)
Özcan, Cengiz; Vayısoglu, Yusuf; Kılıç, Serkan; Görür, Kemal
PUB. DATE
December 2008
SOURCE
Journal of Otolaryngology -- Head & Neck Surgery;Dec2008, Vol. 37 Issue 6, p826
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objective: Our study compared Rapid Rhino (RR; Applied Therapeutic Ltd, Leicestershire, UK) and Merocel (Medtronic Xomed, Jacksonville, FL) nasal packing materials in endonasal septoplasty surgery in terms of postoperative patient comfort and reactionary bleeding. Patients and Methods: Fifty-one patients underwent endonasal septoplasty. One nasal cavity was packed with Merocel packs and the RR pack was used for the other side. The pain and nasal fullness levels on each side were studied at 1 and 6 hours postoperatively. Pain level was also studied during the removal of the nasal packs on the second day. These levels were scored on the basis of a visual analogue scale (VAS) between 0 and 10. Reactionary bleeding after nasal pack removal was also recorded. The Wilcoxon test was used for statistical analysis of the VAS scores, and the McNemar test was used for comparison of bleeding levels after pack removal. A p value < .05 was considered to be statistically significant. Results: Minimal bleeding was noted in 15 patients following Merocel pack removal; however, no bleeding was seen following RR pack removal. Comparison of the VAS scores of pain and nasal fullness of each nasal pack at 1 and 6 hours postoperatively showed a statistically significant difference (p < .05). Similarly, comparison of the pain level for pack removal and bleeding after removal on the second postoperative day demonstrated a statistically significant difference (p < .05 and p = .001, respectively). Conclusion: RR is more tolerable by patients than Merocel after septoplasty surgery. RR also has some advantages, namely, easy pack removal and less reactionary bleeding.
ACCESSION #
36365353

 

Related Articles

  • DLP reaping Medtronic's early rewards. VanderVeen, Don // Grand Rapids Business Journal;7/10/95, Vol. 13 Issue 28, p3 

    Reports that Medtronic Inc.'s division Medtronic Surgical Products has launched its surgical products produced in Grand Rapids, Michigan. Description and applications of the products; Price ranges; Monitoring of the use of the products in operating rooms in the United States to ensure proper...

  • Medtronic releases T2 Altitude Expandable Corpectomy Device.  // Orthopaedics Today Europe;Jan/Feb2012, Vol. 15 Issue 1, p20 

    The article previews the T2 Altitude Expandable Corpectomy Device from Medtronic Inc.

  • Talent Stent Graft launched on new hydro delivery system. YOFFEE, LYNN // Medical Device Daily;11/21/2008, Vol. 12 Issue 228, p1 

    The article announces the launch of Medtronic's Talent Abdominal Stent Graft with Xcelerant Hydro Delivery System.

  • A Simple Technique for Removing the Nuss Bar with One Stabilizer: The Lateral Approach. Varela, Patricio; Romanini, Moria Victoria; Asquasciati, Caterina; Torre, Michele // Journal of Laparoendoscopic & Advanced Surgical Techniques;Jan/Feb2010, Vol. 20 Issue 1, p91 

    The removal of the substernal bar after the Nuss operation is not always an easy and fast maneuver. Only a few different technical solutions have been described. In the original Nuss technique, the patient was lying on dorsal decubitus and rotated on the side during the procedure. The Noguchi...

  • Graft inserters yield similar endothelial cell density after DSAEK. Correa, Mark; Hasson, Matt; Nale, Pat; Pagnani, Michelle; Tan, Donald T. H. // Ocular Surgery News;5/25/2012, p14 

    The article reports a study, in which two graft inserters resulted in similar endothelial cell density after Descemet's stripping automated endothelial keratoplasty; a commentary to the study is also included.

  • Stent patent dispute moves through courts.  // Materials Management in Health Care;Jul2008, Vol. 17 Issue 7, p6 

    The article reports on the decision of the U.S. District Court to award $250 million in damages to Medtronic Inc. after it discovered that Boston Scientific Corp. had infringed on the stent patents of the firm. According to the article, Medtronic arrogated that Boston's the Taxus Express2,...

  • PLANT IS THE BACKBONE OF SPINAL IMPLANT BUSINESS. Demetrakakes, Pan // Food & Drug Packaging;May2007, Vol. 71 Issue 4, p44 

    The article focuses on the Sofamor-Danek production and packaging facility of Medtronic Inc. in Warsaw, Indiana. The facility produces and packages a variety of implant components for spinal surgery. The components packaged at the facility fall into sterile and non-sterile categories. The vast...

  • Product briefs.  // Biomedical Business & Technology;Feb2009, Vol. 32 Issue 2, p30 

    The article focuses on the launch of the Integrated Power Console platform multispecialty surgical power console by Medtronic.

  • Medtronic's Reveal XT device introduced for AF monitoring.  // Medical Device Daily;7/11/2007, Vol. 11 Issue 132, p1 

    The article reports on the launch of the Reveal XT Insertable Cardiac Monitor from Medtronic in Europe. The company claims that the equipment offers long-term and continuous monitoring of atrial fibrillation. It is mentioned that the device has received the Council of Europe (CE)-mark approval...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics